Pages

Tuesday, November 16, 2021

US FDA News: FDA Authorizes Marketing of Virtual Reality System for Chronic Pain Reduction

The FDA authorized marketing of EaseVRx, a prescription-use immersive virtual reality (VR) system that uses cognitive behavioral therapy and other behavioral methods to help with pain reduction in patients 18 years of age and older with diagnosed chronic lower back pain.
Read more: FDA Authorizes Marketing of Virtual Reality System for Chronic Pain Reduction